Medios Past Earnings Performance

Past criteria checks 2/6

Medios has been growing earnings at an average annual rate of 19%, while the Healthcare industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 26.1% per year. Medios's return on equity is 2.5%, and it has net margins of 0.7%.

Key information

19.0%

Earnings growth rate

6.5%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate26.1%
Return on equity2.5%
Net Margin0.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medios makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:ILM1 Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,84213490
30 Jun 241,83816420
31 Mar 241,81018390
31 Dec 231,78519390
30 Sep 231,74319390
30 Jun 231,67318390
31 Mar 231,65018370
31 Dec 221,61218370
30 Sep 221,58113320
30 Jun 221,51611290
31 Mar 221,43610260
31 Dec 211,3597220
30 Sep 211,16311200
30 Jun 219699190
31 Mar 217806180
31 Dec 206276160
30 Sep 205996150
30 Jun 205829140
31 Mar 2056610130
31 Dec 1951810120
30 Sep 194649100
30 Jun 194137100
31 Mar 193716100
31 Dec 183294100
30 Sep 18305490
30 Jun 18282390
31 Mar 18268480
31 Dec 17254470
30 Sep 17224170
30 Jun 17193-280
31 Mar 17163-380
31 Dec 16133-370
31 Dec 1558110

Quality Earnings: ILM1 has high quality earnings.

Growing Profit Margin: ILM1's current net profit margins (0.7%) are lower than last year (1.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ILM1's earnings have grown by 19% per year over the past 5 years.

Accelerating Growth: ILM1's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ILM1 had negative earnings growth (-31.7%) over the past year, making it difficult to compare to the Healthcare industry average (36.2%).


Return on Equity

High ROE: ILM1's Return on Equity (2.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 11:02
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medios AG is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel EnglandBerenberg
Charlotte FriedrichsBerenberg
Maria Vara FernándezBryan Garnier & Co